A MULTICENTER, RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED, PARALLEL-GROUP PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF EPITHELIUM-ON CORNEAL CROSS-LINKING IN SUBJECTS 8 TO 45 YEARS OF AGE WITH KERATOCONUS (APRICITY-B)

Is this Study for You?

Let's Get Started!

Description

To evaluate the efficacy of the riboflavin-sodium iodide solution followed by ultraviolet A (UVA) exposure and epithelium-on corneal crosslinking (CXL) assessed by visual acuity measurement in subjects with keratoconus.

Details
Age

Child to Adult

Eligibility

Males and females ≥ 8 to ≤ 45 years of age with the clinical diagnosis of keratoconus. Diagnosis will be confirmed by tomographic imaging

Locations

University of Colorado Hospital

Principal Investigator
Photograph of Michael Taravella

Michael Taravella

Study ID

Protocol Number: 23-1425

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers